ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company is headquartered in Yokneam Illit, Israel.
| Revenue (TTM) | $22.03M |
| Gross Profit (TTM) | $8.43M |
| EBITDA | $-17.17M |
| Operating Margin | -112.70% |
| Return on Equity | -146.10% |
| Return on Assets | -41.00% |
| Revenue/Share (TTM) | $18.99 |
| Book Value | $5.52 |
| Price-to-Book | 2.39 |
| Price-to-Sales (TTM) | 0.89 |
| EV/Revenue | 1.014 |
| EV/EBITDA | 1.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -32.70% |
| Shares Outstanding | $2.78M |
| Float | $1.52M |
| % Insiders | 0.69% |
| % Institutions | 1.74% |
Volatility is currently contracting